Invitrogen Corporation (IVGN) Launches Solutions to Simplify DNA and RNA Workflows on Next-Generation Sequencing Systems
12/18/2008 9:49:53 AM
CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen, part of Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced the introduction of two reagent solutions to simplify genomic and transcriptome analysis on next-generation, high-throughput genomic analysis platforms. Both solutions provide basic and clinical researchers with an innovative workflow that greatly reduces the time, cost, and experimental variability associated with next-generation sequencing library preparation.
comments powered by